世界の急性骨髄性白血病（AML）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acute Myeloid Leukemia Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0073 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、急性骨髄性白血病（AML）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（パイプライン薬、化学療法薬、化学療法レジメン）、用途別市場規模（病院、クリニック、在宅医療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・急性骨髄性白血病（AML）治療の市場動向 ・企業の競争状況、市場シェア ・急性骨髄性白血病（AML）治療の種類別市場規模（パイプライン薬、化学療法薬、化学療法レジメン） ・急性骨髄性白血病（AML）治療の用途別市場規模（病院、クリニック、在宅医療） ・急性骨髄性白血病（AML）治療の北米市場規模2016-2027（アメリカ、カナダ） ・急性骨髄性白血病（AML）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・急性骨髄性白血病（AML）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・急性骨髄性白血病（AML）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・急性骨髄性白血病（AML）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Ambit Biosciences Corporation、Genzyme Corporation Celgene Corporation、Clavis Pharma ASA、Sunesis Pharmaceuticals、Cephalon、Bristol-Myers Squibb、Novartis International AG、GlaxoSmithKline） ・結論

Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age. Incidence rate of acute myeloid leukemia is high in men and women over 50 years.
Geographically, acute myeloid leukemia therapeutics market is divided into North America, Europe, Asia Pacific, Latin America, and MEA. As of 2014, North America held substantial share of the acute myeloid leukemia therapeutics market owing to prominent growth factors including rising incidences of acute myeloid leukemia and increasing geriatric population. Furthermore, advanced healthcare infrastructure, rising need of targeted therapies, huge investment in the development of pipeline drugs, and awareness amongst the population base induced market growth in this region. Asia Pacific is expected to be the fastest growing region over the forecast period owing to growth factors such as rising investments, rising disposable incomes, increasing cancer awareness, and improving healthcare infrastructure. Additionally, increasing inclination towards therapies such as targeted therapies resulting in low collateral damage and stronger efficacy is also anticipated to propel the demand for the acute myeloid leukemia therapeutics market in this region.

Market Analysis and Insights: Global Acute Myeloid Leukemia Therapeutics Market
The global Acute Myeloid Leukemia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Myeloid Leukemia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Myeloid Leukemia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Myeloid Leukemia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Myeloid Leukemia Therapeutics market.

Global Acute Myeloid Leukemia Therapeutics Scope and Market Size
Acute Myeloid Leukemia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Myeloid Leukemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pipeline Drugs
Chemotherapy Drugs
Chemotherapy Regimens

Segment by Application
Hospitals
Clinics
Home Care

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Ambit Biosciences Corporation
Genzyme Corporation Celgene Corporation
Clavis Pharma ASA
Sunesis Pharmaceuticals
Cephalon
Bristol-Myers Squibb
Novartis International AG
GlaxoSmithKline

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pipeline Drugs
1.2.3 Chemotherapy Drugs
1.2.4 Chemotherapy Regimens
1.3 Market by Application
1.3.1 Global Acute Myeloid Leukemia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Myeloid Leukemia Therapeutics Market Perspective (2016-2027)
2.2 Acute Myeloid Leukemia Therapeutics Growth Trends by Regions
2.2.1 Acute Myeloid Leukemia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Myeloid Leukemia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Acute Myeloid Leukemia Therapeutics Industry Dynamic
2.3.1 Acute Myeloid Leukemia Therapeutics Market Trends
2.3.2 Acute Myeloid Leukemia Therapeutics Market Drivers
2.3.3 Acute Myeloid Leukemia Therapeutics Market Challenges
2.3.4 Acute Myeloid Leukemia Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Myeloid Leukemia Therapeutics Players by Revenue
3.1.1 Global Top Acute Myeloid Leukemia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Acute Myeloid Leukemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Myeloid Leukemia Therapeutics Revenue
3.4 Global Acute Myeloid Leukemia Therapeutics Market Concentration Ratio
3.4.1 Global Acute Myeloid Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Therapeutics Revenue in 2020
3.5 Acute Myeloid Leukemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Acute Myeloid Leukemia Therapeutics Product Solution and Service
3.7 Date of Enter into Acute Myeloid Leukemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Myeloid Leukemia Therapeutics Breakdown Data by Type
4.1 Global Acute Myeloid Leukemia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Acute Myeloid Leukemia Therapeutics Breakdown Data by Application
5.1 Global Acute Myeloid Leukemia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Myeloid Leukemia Therapeutics Market Size (2016-2027)
6.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Type
6.2.1 North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027)
6.3 North America Acute Myeloid Leukemia Therapeutics Market Size by Application
6.3.1 North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027)
6.4 North America Acute Myeloid Leukemia Therapeutics Market Size by Country
6.4.1 North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acute Myeloid Leukemia Therapeutics Market Size (2016-2027)
7.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type
7.2.1 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application
7.3.1 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Acute Myeloid Leukemia Therapeutics Market Size by Country
7.4.1 Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Myeloid Leukemia Therapeutics Market Size (2016-2027)
9.2 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type
9.2.1 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application
9.3.1 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country
9.4.1 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Ambit Biosciences Corporation
11.1.1 Ambit Biosciences Corporation Company Details
11.1.2 Ambit Biosciences Corporation Business Overview
11.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Introduction
11.1.4 Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.1.5 Ambit Biosciences Corporation Recent Development
11.2 Genzyme Corporation Celgene Corporation
11.2.1 Genzyme Corporation Celgene Corporation Company Details
11.2.2 Genzyme Corporation Celgene Corporation Business Overview
11.2.3 Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Introduction
11.2.4 Genzyme Corporation Celgene Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.2.5 Genzyme Corporation Celgene Corporation Recent Development
11.3 Clavis Pharma ASA
11.3.1 Clavis Pharma ASA Company Details
11.3.2 Clavis Pharma ASA Business Overview
11.3.3 Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Introduction
11.3.4 Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.3.5 Clavis Pharma ASA Recent Development
11.4 Sunesis Pharmaceuticals
11.4.1 Sunesis Pharmaceuticals Company Details
11.4.2 Sunesis Pharmaceuticals Business Overview
11.4.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Introduction
11.4.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.4.5 Sunesis Pharmaceuticals Recent Development
11.5 Cephalon
11.5.1 Cephalon Company Details
11.5.2 Cephalon Business Overview
11.5.3 Cephalon Acute Myeloid Leukemia Therapeutics Introduction
11.5.4 Cephalon Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.5.5 Cephalon Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Introduction
11.6.4 Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Novartis International AG
11.7.1 Novartis International AG Company Details
11.7.2 Novartis International AG Business Overview
11.7.3 Novartis International AG Acute Myeloid Leukemia Therapeutics Introduction
11.7.4 Novartis International AG Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.7.5 Novartis International AG Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Introduction
11.8.4 GlaxoSmithKline Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pipeline Drugs
Table 3. Key Players of Chemotherapy Drugs
Table 4. Key Players of Chemotherapy Regimens
Table 5. Global Acute Myeloid Leukemia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acute Myeloid Leukemia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acute Myeloid Leukemia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions (2022-2027)
Table 11. Acute Myeloid Leukemia Therapeutics Market Trends
Table 12. Acute Myeloid Leukemia Therapeutics Market Drivers
Table 13. Acute Myeloid Leukemia Therapeutics Market Challenges
Table 14. Acute Myeloid Leukemia Therapeutics Market Restraints
Table 15. Global Acute Myeloid Leukemia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Acute Myeloid Leukemia Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Acute Myeloid Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia Therapeutics as of 2020)
Table 18. Ranking of Global Top Acute Myeloid Leukemia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Acute Myeloid Leukemia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Acute Myeloid Leukemia Therapeutics Product Solution and Service
Table 22. Date of Enter into Acute Myeloid Leukemia Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Acute Myeloid Leukemia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Ambit Biosciences Corporation Company Details
Table 63. Ambit Biosciences Corporation Business Overview
Table 64. Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Product
Table 65. Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Ambit Biosciences Corporation Recent Development
Table 67. Genzyme Corporation Celgene Corporation Company Details
Table 68. Genzyme Corporation Celgene Corporation Business Overview
Table 69. Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Product
Table 70. Genzyme Corporation Celgene Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Genzyme Corporation Celgene Corporation Recent Development
Table 72. Clavis Pharma ASA Company Details
Table 73. Clavis Pharma ASA Business Overview
Table 74. Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Product
Table 75. Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Clavis Pharma ASA Recent Development
Table 77. Sunesis Pharmaceuticals Company Details
Table 78. Sunesis Pharmaceuticals Business Overview
Table 79. Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Product
Table 80. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Sunesis Pharmaceuticals Recent Development
Table 82. Cephalon Company Details
Table 83. Cephalon Business Overview
Table 84. Cephalon Acute Myeloid Leukemia Therapeutics Product
Table 85. Cephalon Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Cephalon Recent Development
Table 87. Bristol-Myers Squibb Company Details
Table 88. Bristol-Myers Squibb Business Overview
Table 89. Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Product
Table 90. Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Bristol-Myers Squibb Recent Development
Table 92. Novartis International AG Company Details
Table 93. Novartis International AG Business Overview
Table 94. Novartis International AG Acute Myeloid Leukemia Therapeutics Product
Table 95. Novartis International AG Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Novartis International AG Recent Development
Table 97. GlaxoSmithKline Company Details
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 100. GlaxoSmithKline Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Myeloid Leukemia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Pipeline Drugs Features
Figure 3. Chemotherapy Drugs Features
Figure 4. Chemotherapy Regimens Features
Figure 5. Global Acute Myeloid Leukemia Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Home Care Case Studies
Figure 9. Acute Myeloid Leukemia Therapeutics Report Years Considered
Figure 10. Global Acute Myeloid Leukemia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Acute Myeloid Leukemia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Acute Myeloid Leukemia Therapeutics Market Share by Players in 2020
Figure 15. Global Top Acute Myeloid Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia Therapeutics Revenue in 2020
Figure 17. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Acute Myeloid Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Acute Myeloid Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Share by Region (2016-2027)
Figure 39. China Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Acute Myeloid Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Ambit Biosciences Corporation Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 59. Genzyme Corporation Celgene Corporation Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 60. Clavis Pharma ASA Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 61. Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 62. Cephalon Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 64. Novartis International AG Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---